ABOUT BOOK

... bone marrow in a patient undergoing 131I therapy to treat thyroid carcinomas . During these 131I therapies , the bone marrow can receive a dose of 1-5 Gy ( Tubiana 1982 ) . This has been shown to lead to a 1 % incidence of leukemia in ...